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expenditure and deﬁned daily doses (DDD) per 1000
inhabitants/day. Drugs are examined according to the
ATC (Anatomic Therapeutic Chemical) classiﬁcation.
The main indicator for hospital admissions is the number
of admissions per 1000 inhabitants/year. Our preliminary
analysis focused on respiratory drugs and hospital ad-
missions for asthma and COPD in Modena districts.
RESULTS: In year 2000, overall and per person expen-
diture for respiratory drugs were €6.614.098 (7.5% of
total expenditure) and €10.6, respectively. We observed
variability in drug prescription among districts: extreme
values were reported for districts of Mirandola, 44.1
DDD per 1000 inhabitants/day, and Carpi, 35.3. Asthma
and BPCO admission rates showed a broad variability as
well: 3.2 and 3.3 admissions per 1000 inhabitants/year
for Carpi and Mirandola, respectively, and 8.4 for
Pavullo. Our analysis showed no correlation between
drug prescription and hospital admission: districts with
similar admission rates (Mirandola and Carpi) reported
quite different values in drug prescription. CONCLU-
SIONS: These preliminary ﬁndings are the starting point
for more speciﬁc analyses that will explore possible deter-
minants of the observed variability in order to increase
appropriate use of drugs.
RESPIRATORY DISORDERS—Cost Studies
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Objective: The objective of this analysis is cost-effective-
ness comparison of bupropion SR in the treatment of
tobacco dependence versus: placebo, nicotine replace-
ment therapy (NRT), bupropion SR used in combination
with NRT (BUPR+NRT). METHODS: The efﬁcacy
analysis was carried in accordance with guidelines for 
systematic review basing on credibility criteria of the
Cochrane Collaboration—Cochrane Reviewers’ Hand-
book and Evidence Based Medicine. Cost analysis
included direct costs from payer’s extended perspective
(public resources and the patient), collected in Poland.
Sensitivity analysis was performed, with consideration of
the variable costs of NRT. RESULTS: The results of meta-
analyses showed a statistically signiﬁcant increase of suc-
cessful attempts of tobacco cessation with the use of
bupropion versus placebo by 10.7% per year (ARR).
Bupropion also shows a statistically signiﬁcant superior-
ity in relation to NRT. The odds ratio of one year-long
abstinence with the use of bupropion versus NRT is 2.0
[CI 95% (1.2–3.4)]. The economic analysis has shown
that the most cost-effective is bupropion used in combi-
nation with medical advice. The cost of maintaining absti-
nence for the lifetime as a result of the use of bupropion
in combination with medical advice, calculated for one
patient, is €2,948,70; cost for LYG is €1,474,35; cost for
QALY is €1,092,23 (2002 average exchange rate: €1 =
3,86 PLN). The least favourable is NRT. The technology
being the combination of NRT and bupropion has inter-
mediate cost-effectiveness results. The cost of medical
advice has not been considered in the analysis. CON-
CLUSIONS: It may be stated that bupropion is a medic-
inal product statistically signiﬁcantly more effective
versus placebo and NRT in the treatment of nicotine
dependence. Bupropion is a cost-effective technology,
where the cost for LYG is signiﬁcantly lower than the
cost-effectiveness threshold (€10,362,69/dialysother-
apy/patient per year).
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OBJECTIVE: Acute lung failure (ALF), often resulting
from pneumonia and/or aspiration, is associated with
high mortality. The objective of this study was to estimate
the resource burden of ALF events by characterizing
pneumonia-associated ALF using NHDS 2000 data. It
was hypothesized that using ALF diagnosis codes alone
may not capture all events; ventilation may be an impor-
tant indicator. METHODS: A base population was ed
using pre-deﬁned diagnosis codes for pneumonia and
aspiration. It was stratiﬁed using various combinations of
diagnostic and procedure groupings: pneumonia, aspira-
tion, or both; ALF; intubation and ventilation use; 
discharge status; and age. Weighting allowed for 
extrapolation to the U.S. civilian population. RESULTS:
Of the estimated 35,348,186 U.S. hospital discharges in
2000, 2,388,996 (6.8%) were associated with pneumo-
nia and/or aspiration. Of these, 192,975 (8.1%) required
ventilation, with approximately 82,840 (43%) of them
requiring ventilation for ≥96 hours. Comparatively,
278,678 (11.7%) of pneumonia and/or aspiration dis-
charges were coded as ALF; approximately 64,194 (23%)
of them required ventilation for ≥96 hours. Note that
overlap exists among these 2 subgroups (38.9% with
both ventilation and ALF), but was not extensive as
hypothesized. Of pneumonia and/or aspiration discharges
with ventilation for ≥96 hours, median length of stay
(LOS) was 19 days when discharged alive and 15 days
when discharged dead (overall median = 18 days). Of
pneumonia and/or aspiration discharges with ventilation
for <96 hours, median LOS was 8 days when discharged
alive and 4 days when discharged dead (overall median =
7 days). CONCLUSIONS: The NHDS is a useful resource
for estimating the economic burden of ALF during hos-
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pitalization. However, subpopulations must be clearly
speciﬁed to avoid erroneous estimates. Ventilation use
among subgroups varies depending on diagnoses and 
procedures speciﬁed. Since length of ventilation appears
related to overall LOS and resource demands, estimations
of cost burden will vary by subgroup deﬁnition for ALF.
RESPIRATORY DISORDERS—Quality of Life
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OBJECTIVES: Health Related Quality of Life (HRQL)
following lung transplantation (LGTX) becomes more
important with increased life expectancy. Analyses are
often hampered by a relatively large number of patients
who drop out, due to their condition or death. This
problem of missing values is of real importance, and
cannot be neglected. In the present study the change in
HRQL before and after LGTX was analysed as a func-
tion of several predictors, assuming that the probability
of missing only depended on the observed measurements
(Missing at Random). METHODS: Between 1992 and
2002, 415 patients completed one or more self-adminis-
tered HRQL questionnaires before and up to 63 months
after LGTX. The questionnaires were sent by mail on a
regular basis. In this study we focus on one dimension of
the energy Nottingham Health Proﬁle. A multi-level
model was used to analyse the changes in this dimension
as a function of several predictors. Since multi-level struc-
tures do not require balanced data to obtain efﬁcient 
estimates, all patients who completed at least one ques-
tionnaire were taken into account. RESULTS: The dimen-
sion energy of the NHP improved signiﬁcantly after
LGTX. This remained more or less constant up to 63
months after LGTX. The predictors “age” and “the pres-
ence of Bronchiolitis Obliterans Syndrome (BOS)”
appeared to have a signiﬁcant inﬂuence. For pre- and
post-transplantation patients, the scores on the dimension
energy increased with age. This means that older patients
have more restrictions regarding energy than younger
patients. After the onset of BOS, patients experienced sig-
niﬁcantly more restrictions in the NHP energy measure.
CONCLUSION: There are considerable improvements
regarding the NHP dimension energy after lung trans-
plantation. Age and BOS are highly signiﬁcant predictors.
The improvements are maintained during long-term
follow-up.
SKIN DISORDERS/DISEASES
SKIN DISORDERS—Clinical Outcomes Studies
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OBJECTIVES: Feet disorders among the older population
have a signiﬁcant effect on individual quality of life, espe-
cially on walking ability, and therefore on the cost 
of health care. The objective was to design a Spanish
national campaign, with the participation of dermatolo-
gists and podiatrists in order to estimate the preval-
ence of feet disorders among the elderly population.
METHODS: The campaign was addressed to users of the
Instituto de Migraciones y Servicios Sociales (IMSERSO)
thermal programme aged over-60 was designed. In each
spa, a team made up of a dermatologist and a podiatrist
assessed the feet of the volunteers. The campaign lasted
for one month, during the weekends. A questionnaire to
collect dermatological and podiatric clinical data was
designed and was previously approved by all investiga-
tors as well as the procedural methods during the feet
examination in a consensus meeting. RESULTS: Data was
collected from 4065 volunteers, and 3925 were analysed.
Advertising posters in the spas and campaign information
in the welcome letters induced the user participation.
From the users revised 2893 (72.8%) were women (mean
age 71.4; SD: 5.8). Seventy-eight percent showed derma-
tological pathology and 90.7% podiatric disorders. The
most common dermatological diseases were ungueal dys-
trophy (35.1%), Tinea Pedis: 23.1% and onychomycosis:
20.8%. The most common podiatric disorders were
hyperkeratosis (58.1%), hallux valgus (43.8%) and claw
toes (28.9%). More than 70% suffered concomitant der-
matological and podiatric pathologies and only 2.9% 
had a normal foot (p < 0.01). CONCLUSIONS: Some
detected feet disorders, such as mycotic infections, should
be approached through an effective treatment and pre-
ventive measures. Our results suggest the need for greater
sensitivity towards feet pathology in the clinical practice
with elderly people. Multidisciplinary studies design in
some populations, mainly in the elderly, are desirable to
deﬁne combined and speciﬁc interventions.
